{{Rsnum
|rsid=2143571
|Gene=SAMM50
|Chromosome=22
|position=43995806
|Orientation=plus
|GMAF=0.3219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SAMM50
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 26.5 | 69.0
| HCB | 15.3 | 45.3 | 39.4
| JPT | 23.9 | 42.5 | 33.6
| YRI | 18.4 | 51.7 | 29.9
| ASW | 7.0 | 52.6 | 40.4
| CHB | 15.3 | 45.3 | 39.4
| CHD | 15.6 | 45.9 | 38.5
| GIH | 6.9 | 38.6 | 54.5
| LWK | 11.8 | 50.0 | 38.2
| MEX | 12.1 | 44.8 | 43.1
| MKK | 8.3 | 43.6 | 48.1
| TSI | 3.9 | 30.4 | 65.7
| HapMapRevision=28
}}{{omim
|desc=ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS
|id=612364
|rsnum=2143571
}}

{{PMID Auto
|PMID=18940312
|Title=Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
|OA=1
}}

{{PMID Auto GWAS
|PMID=22719876
|Trait=None
|Title=Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese.
|RiskAllele=A
|Pval=6E-7
|OR=1.4700
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=23535911
|Title=Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}